Concepedia

J. David Leander

JD

Statistics

Publications

118

Citations

5.2K

H-Index

41

Active since

1968

Affiliations

Eli Lilly (United States)(Current)

University of North Carolina at Chapel Hill

J. David Leander is an author at Eli Lilly (United States) specializing in pharmacology, medicine, and neuropharmacology.

Publications per year

1968–2017

118

Publications

118

GLYX-13, a NMDA Receptor Glycine-Site Functional Partial Agonist, Induces Antidepressant-Like Effects Without Ketamine-Like Side Effects

Jeffrey Burgdorf, Xiaolei Zhang, Katherine L. Nicholson et al. · Neuropsychopharmacology · 2012 · 282 citations · Full text

, , +14

A kappa opioid effect: increased urination in the rat.

J. David Leander · Journal of Pharmacology and Experimental Therapeutics · 1983 · 226 citations

, , +16

The absolute configurations and pharmacological activities of the optical isomers of fluoxetine, a selective serotonin-uptake inhibitor

David W. Robertson, Joseph H. Krushinski, R W Fuller et al. · Journal of Medicinal Chemistry · 1988 · 162 citations

, , +16

The effect of streptozotocin-induced diabetes on cell proliferation in the rat dentate gyrus

Joy Jackson-Guilford, J. David Leander, Laura K. Nisenbaum · Neuroscience Letters · 2000 · 141 citations

, , +8

The effects of hippocampectomy on alternation behavior and response to novelty

Larry W. Means, J. David Leander, Robert L. Isaacson · Physiology & Behavior · 1971 · 141 citations

, , +12

1–5 of 118